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Previously, we and others have shown that MHC class-II deficient humans have greatly
reduced numbers of CD4+CD8- peripheral T cells. These type-III Bare Lymphocyte
Syndrome patients lack MHC class-II and have an impaired MHC class-I antigen
expression. In this study, we analyzed the impact of the MHC class-II deficient
environment on the TCR V-gene segment usage in this reduced CD4+CD8- T-cell
subset. For these studies, we employed TcR V-region-specific monoclonal antibodies
(mAbs) and a semiquantitative PCR technique with Vo and Vfl amplimers, specific for
each of the most known Vow- and V//-gene region families. The results of our studies
demonstrate that some of the Vc-gene segments are used less frequent in the
CD4+CD8- T-cell subset of the patient, whereas the majority of the TCR Vow- and
gene segments investigated were used with similar frequencies in both subsets in the
type-III Bare Lymphocyte Syndrome patient compared to healthy control family
members. Interestingly, the frequency of TcR V12 transcripts was greatly diminished
in the patient, both in the CD4+CD8- as well as in the CD4-CD8+ compartment,
whereas this gene segment could easily be detected in the healthy family controls. On
the basis of the results obtained in this study, it is concluded that within the reduced
CD4+CD8- T-cell subset of this patient, most of the TCR V-gene segments tested for are
employed. However, a skewing in the usage frequency of some of the Vo-gene segments
toward the CD4-CD8+ T-cell subset was noticeable in the MHC class-II’deficient patient
that differed from those observed in the healthy family controls.
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INTRODUCTION
During T-cell development, positive and nega-
tive selection events occur within the thymic
microenvironment that influence in part the com-
position of the mature peripheral T-cell compart-
ment (Fink and Bevan, 1978; Zinkernagel et al.,
1978; Sprent et al., 1988; Schwartz, 1989; Nikolic-
Zugic and Bevan, 1990; Teh et al., 1991). Inter-
actions between T-cell receptor (TcR) and MHC
class-I or class-II antigens play a pivotal role in
this process. As a result, only T cells bearing TcRs
with moderate affinity for "self" MHC class I or
class II can be found in the’periphery (Marrack et
al., 1988).
*Corresponding author.
The avidity of a given TcR, expressed on the
double-positive thymocyte (CD4+CD8+), for a
MHC class-I or class-II antigen dictates the
resulting single-positive phenotype (CD4+CD8-
or CD4-CD8+) of the mature T cell (Kaye et al.,
1989; von Boehmer et al., 1989; Teh et al., 1990).
However, the specificity of TcRs for MHC class-I
or-II antigens can be influenced in part by the
coexpressed accessory molecules (CD4 or CD8,
respectively; Robey et al., 1991). Interference in
the interactions involved in this selection process
has a dramatic effect on the composition of the
peripheral T-cell compartment. (1) Disturbance
of the TcR/MHC class-II antigen interaction in
neonates due to masking of I-A antigens with
anticlass-II monoclonal antibodies results in
diminished numbers of peripheral CD4+CD8- T
cells (Kruisbeek et al., 1983, 1985). (2) Mice that
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lack class-I heavy-chain expression due to a dis-
rupted 2-microglobulin (2m) gene have greatly
reduced numbers of CD4-CD8+ peripheral T
cells (Koller et al., 1990; Zijlstra et al., 1990).
The diversity of TcRs is generated in part
through the use of various different Vow- and V]/-
gene segments This V-gene segment use how-
ever is not random, but is influenced by the MHC
haplotype, as has been shown in mice (Benoist
and Mathis, 1989; Bill and Palmer, 1989). As a
result, use of certain TcR V-gene segment famil-
ies can be strongly biased to either the
CD4+CD8-or CD4-CD8+ population or com-
plet61y deleted in both subsets (Liao et al., 1990;
Singer et al., 1990). Analysis of the TcR V-gene
segment use of clones sharing reactivity to a cer-
tain peptide showed that in mice these clones
often use a limited Vo and Vfl repertoire (Fink et
al., 1986; Engel and Hendrik, 1988). In man, also
a restricted TcR Vow- and Vfl-gene segment use in
clones reactive to a defined peptide has been
reported (Wucherpfennig et al., 1990; Ben-Nun et
al., 1991).
The impact of MHC class-II antigen expression
on the selection of the peripheral T-cell repertoire
in man can be studied in patients with the Bare
Lymphocyte Syndrome (BLS) (also referred to as
MHC class-II deficiency syndrome). This syn-
drome is a lethal combined immunodeficiency
often associated with opportunistic infections
and malabsorptiofi. The main characteristic of
this syndrome is defective MHC class-II antigen
expression (type-II BLS), sometimes in combi-
nation with a reduced MHC class-I expression
(type-III BLS), on cells that normally express
these antigens, including those involved in thy-
mic differentiation (Touraine et al., 1978; Schuur-
man et al., 1979; Schuurman et al., 1985; Rijkers et
al., 1987). The lack ofMHC class-II in conjunction
with aberrant class-I expression was also notice-
able in established EBV transformed B-cell lines
and T-cell lines (Bull et al., 1990; Lambert et al.,
1990; Lambert et al., 1991). Previously, we and
others (Zegers et al., 1984; Rijkers et al., 1987;
Lambert et al., 1991) have shown that in a human
environment devoid of MHC class-II antigen
expression, the numbers of peripheral
CD4+CD8- T cells are greatly reduced. In
addition, these CD4+CD.8- cells have an in vitro
proliferative disadvantage compared .to
CD4+CD8- cells derived from healthy controls
(Lambert et al., 1991).
In this study, we have analyzed the impact of
the MHC class-II deficient environment on the
relative frequencies of TCR Vow- and V]/-gene seg-
ment use in the CD4+CD8- peripheral T-cell sub-
set of a type-III BLS patient.
MATERIALS AND METHODS
T-Cell Lines and Clones
T-cell lines were derived from blood samples
obtained from a type-III BLS patient (MBI; A28,
A2, B13, B39, CW6) and relatives (Father ZBI; A2,
All, B39, B52, CW-, DR2, DQwl, Mother KBI;
A28, A26, B13, B44, Cw6, DR7, DR4, DQw2,
DQw3 and a fetal sibling FBI; A26, All, B44, B52,
Cw-, DR4, DR2, DQw2, DQwl). Blood from the
fetus was obtained via direct umbilical-cord
puncture. Peripheral blood mononuclear cells
(PBMC) were isolated by Fycoll/Isopaque gradi-
ent centrifugation and stimulated by polyclonal
activation with 0.5% PHA (Wellcome) and 100 u.
rIL-2 (Cetus) in the presence of irradiated
(2500rad) allogeneic feeder cells in Iscove’s
Modified Dulbecco’s Medium (IMDM) contain-
ing 10% human AB serum. One week following
the initial stimulation, small aliquots were frozen
in medium containing 20% human serum and
10% DMSO for cryopreservation in liquid
nitrogen.
Aliquots were thawed and stained with anti-
CD4 and anti-CD8 monoclonal antibodies.
CD4+CD8- and CD4-CD8+ T cells were isolated
by FACS sorting. CD4+CD8-clones were estab-
lished by limiting dilution of stained and sorted
CD4+CD8- PBMC from the patient. Isolated cell
populations were restimulated with 0.5% PHA
and 100 u. rIL-2 in the presence of allogeneic
feeder cells for another 2 weeks. Viable cells .were
isolated by Fycoll/Isopaque gradient centrifu-
gation and CD4 and CD8 expression was deter-
mined by staining with anti-CD4 and anti-CD8
monoclonal antibodies on a FACScan.
cDNA Synthesis and PCR
Total RNA was isolated by the RNAzol method
(Cinna/Biotecx) according to the manufacturer’s
instructions. Five micrograms of total RNA was
used for the synthesis of first-strand cDNA using
oligo-dT as a primer (Promega, Madison,T-CELL SUBCULTURES DERIVED FROM A TYPE-III 229
Wisconsin). An aliquot of the cDNA preparation
was subjected to amplification with 2.5 units of
Taq polymerase (Amplitaq, Cetus Corporation,
Emeryville, California) in the following reaction
mixture: 20 pmol of specific Vo or Vfl primer,
and 20 pmol of Co or C primer, respectively,
50 mM KC1, 10 mM Tris-HC1 (pH 8.4), 4 mM
MgC12, 0.5 mM each of dNTP, and 0.06 mg/ml
bovine serum albumin .(BSA) in a final volume of
100 ill. Sequences of used primers were pub-
lished by Wucherpfennig et al. (1990) (V]J 1 to Vfl
16 except V12) and by Oksenberg et al. (1990)
(V/2, 3, 5-9, 11, 12). The Vof17-21 oligonucleo-
tides have been described as Vof13-17 by Oksen-
berg et al. (1990). Sequences of additional pri-
mers were
Primer
V]J12
V]J17
V]J18
V]J19
V//20
5’C
3’C]/
Vrxl
Vow4
Vofl3
Vofl4
Vofl5
Vo16
Vo22
5’Co
3’Co
Sequence
5’CTGAGATGTCACCAGACTGAGAACCACCGC 3’
5’GCACAAGAAGCGATTCTCATCTCAATGCCC 3’
5’CATCTGTCTTCTGGGGGCAGGTCTCTCAAA 3’
5’ATAGCTGAAGGGTACAGCGTCTCTCGGGAG 3’
5’TCTAATATTCATCAATGGCCAGCGACCCT 3’
5’CCGAGGTCGCTGTGTTTGAGCCAT 3’
5’CTCTTGACCATGGCCATC 3’
5’TTGCCCTGAGAGATGCCAGAG 3’
5’AAGACAGAAAGTCCAGTACCTTGATCCTGC 3’
5’TGCTGTGTGAGAGGAATACAAGTG 3’
5’GATCTCCACCTGTCTTGAATTTAG 3’
5’CAGAGTCTTTTCCTGAGTGTCCGAG 3’
5’GAGTGGGCTGAGAGCTCAGTCAGTG 3’
5’ATGTCAGGCAATGACAAGGGAAGC 3’
5’GAACCCTGACCCTGCCGTGTACC 3’
5’ATCATAAATTCGGGTAGGATCC 3’
The profile of the PCR cycles was as follows:
denaturation at 95C for 60 s, annealing at 55C
for 60 s and elongation at 72C for 60 s in a Bio-
Med Thermocycler 60. Amplifications were per-
formed for a maximum of 40 cycles to determine
trace amounts of specific V-gene segment usage.
After 25 (Vc) or 20 (V/J) cycles of amplification,
aliquots were drawn and used for Southern blot
analysis. The PCR products were size fraction-
ated on a 0.8% agarose gel and transferred to
Gene Screen Plus (NEN). TcR-specific DNA
sequences were detected by hybridization using
an internal 32p labeled Co or C/J probe, respect-
ively (Yoshikai et al., 1984; Yanagi et al., 1985).
Transfer and hybridization were performed
according to the manufacturer’s instructions.
MHC class II transcription analysis (DR, DP,
and DQ A and B chains) was performed as
described (Lambert et al., 1991). Transfer and
hybridizations were performed as described
before. MHC class-II specific sequences were vis-
ualized using probes from the Xth International
HLA workshop.
Flow Microfluorometric Analysis
Cells were analyzed by indirect immunofluores-
cence on a flow cytometer (FACScan, Becton-
Dickinson). Cells were washed with PBS contain-
ing 1% BSA and 0.1% sodium azide. Aliquots of 1
105 cells were incubated at 4C with monoclonal
antibodies (mAb) for 30 min, either directly ana-
lyzed when conjugated mAbs were used, or
washed and reincubated with fluorescein-iso-
thiocyanate-conjugated rabbit antimouse im-
munoglobulin F(ab) fragments (Dakopatts).
After another 30 min, cells were washed three
times and analyzed. The used monoclonal anti-
bodies were anti-CD4Ft and anti-CD8eE (Becton-
Dickinson) and antibodies that are specific for
family members belonging to the TcRVflS-, V/6-,
Vfl8-, Vf112-, and VcC2-gene segment family
(Diversi-T, T cell Science) and Vc12
(DerSimonian et al., 1991).
RESULTS
Immunofluorescence Analysis
In previous studies, we have shown that despite
the apparent lack of MHC class-II antigen
expression in the typeSIII Bare Lymphocyte Syn-
drome (BLS) patient MBI, CD4+CD8- T cells can
be found among PBMC, albeit their numbers are
reduced (ratio CD4+/CD8+=0.75; Lambert et al.,
1991). Of interest was the observation that within
the CD4+CD8- subset, 48% of the CD4+CD8- T
cells coexpressed the CD45RO marker, which is
characteristic for activated T cells. As shown in
Fig. 1, the T-cell lines derived from patient MBI
(type-III BLS) lacked detectable levels of MHC
class-II transcripts as determined by polymerase
chain reaction (PCR) as well as staining with
anti-HLA class-II specific monoclonal antibodies
(Lambert et al., 1991).
To address the question whether the lack of
MHC class-II antigen expression has an impact
on the composition of this impaired peripheral
CD4+ T-cell subset with respect to employment
of the various TcR V-gene segments, we studied
the frequency of TcR Vow- and V]J-gene segment
use in these cells. PBMC were stained with mon-230 M. LAMBERT et al.
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FIGURE 1. MHC class-II expression in T-cell lines derived from patient MBI (lanes 2, 4, 6, 8, 10, 12) and healthy control KBI
(lanes 1,3, 5, 7, 9, 11) by PCR/Southern analysis. 1-2: DR-A; 3-4: DR-B; 5-6: DQ-A; 7-8: DQ-B; 9-10: DR-A; 11-12: DP-B; and Co (1:
KBI; 2: BI).
TABLE
Flow Cytometric Analysis of TcR Expression on PBMC
Derived from MHC Class-II Deficient Patient (MBI) and Two
Healthy Family Controls (ZBI, KBI)
Vo:2 V]J5a V/J5b V/J6 V]J8 V]J12
MBI 3.7 7.4 5.1 5.6 11.0 1.8
KBI 2.8 2.8 3.8 2.0 7.0 2.5
ZBI 4.7 7.0 2.5 5.2 8.4 4.3
’Results expressed percentage positive cells.
oclonal antibodies specific for the TcR V]15-, 6-,
8-, 12- and Vo:2-gene segment families. The
results of these analyses, summarized in Table 1,
show that all tested TcR V-region families were
expressed in the patient-derived PBMC. The
observed frequencies in the patient-derived
material were within normal range. Variation in
the frequency of use of the different V-gene fam-
ilies was noticeable when the different indi-
viduals were compared. In general, the percent-
age of T cells carrying a particular V-gene
segment was always less than 10%, except for
8 in the patient-derived PBMC (see Table 1). The
relative high frequency of V]J8 positive cells seen
in the patient and healthy controls was also
observed in PBMC derived from other, unrelated
individuals using the same antibody (data not
shown).
To determine the TcR V]/and Vo use in the
individual CD4+CD8- and CD4-CD8+ T-cell
populations, in vitro expanded T cells were iso-
lated by FACS sorting and analyzed (Table 2). In
the patient-derived material, all tested Vow- and
TABLE 2
Flow Cytometric Analysis of TcR Expression on In Vitro Activated CD4+CD8- and CD4-CD8+ T Cells Derived from a Bare
Lymphocyte Type-III patient (MBI) and Two Healthy Family Controls (ZBI, KBI)
V2 Vod2 V]J5a Vfl5b V]/6 V]J8 V/J12
MBI CD4+ 3.5 0.5 2.5 2.0 3.4 4.1 2.6
CD8+ 7.0 0.4 1.9 0.9 3.4 5.7 1.6
KBI CD4+ 2.4 n.t. 1.4 1.0 2.0 6.7 1.2
CD8+ 0.1 2.7 9.9 6.5 0.2 0.8 0.1
ZBI CD4+ 4.3 2.3 3.6 1.7 5.2 13.0 4.1
CD8+ 4.4 5.2 2.3 1.5 3.7 8.9 1.8
’Results expressed percentage positive cells.T-CELL SUBCULTURES DERIVED FROM A TYPE-III 231
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FIGURE 2. TcR Vfl-gene segment usage in T-cell cultures derived from a MHC class-II deficient patient (MBI), a healthy sibling
(FBI), and parents (KBI, ZBI) determined by semiquantitative PCR.232 M. LAMBERT et al.
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FIGURE 3. TcR Vcc-gene segment usage in T-cell cultures derived from a MHC class-II deficient patient (MBI), a healthy sibling
(FBI), and parents (KBI, ZBI) determined by semiquantitative PCR.T-CELL SUBCULTURES DERIVED FROM A TYPE-III 233
Vfl-gene segment families could be detected both
in the CD4 and CD8 positive population with the
exception of Vcz12. The frequency of T cells reac-
tive with the monoclonal antibodies used was in
most cases comparable with the frequencies
found in the cell cultures derived from the non-
MHC class-II deficient relatives. Of note is the
apparent skewing of the Va’2 and V8 V-regions
toward the CD4-CD8+ subset in the MHC class-
II deficient patient that was not observed in
material derived from both healthy family mem-
bers (Table 2).
TcR V-Gene Segment Usage as Determined by
PCR Analysis
TABLE 3
Analysis of TcR Vcz and V]/Usage in CD4+CD8- T-Cell Clones
Derived from a MHC Class-II Deficient Patient
Clone Vz
M4C2 N.D. 19
M4C3 2, 4 10
M4C4 4 9
M4C5 11 3
M4C8 4 3
M4C9 15 20
M4C10 17 19
M4Cll 8 2
M4C12 21, 2 19
M4C13 3 7
M4C16 10 15
M4C17 11 7
M4C18 4 5
M4C19 4 5
TcR Vcz- and V]/-gene segment usage determined by PCR analysis.
V-gene family usage
Next, we have expanded our analyses of the TCR
V-gene segment use at the transcriptional level
by PCR. To this end, 19 different oligonucleotides
were used to amplify the different Vl/-gene seg-
ment families. The results of these PCR analyses
show that both in the CD4+CD8- and CD4-CD8+
T-cell subsets, nearly all TCR V]/ families tested
could be detected (Fig. 2). In general, TcR VI/-
gene segment families with the most members
showed the strongest amplification. An exception
was V119, which has only one member and was
strongly amplified in 011 individuals, both in the
CD4+CD8- and CD4-CD8+ T-cell population.
Some TcR Vl/-gene segment families were used at
almost equal frequencies in both CD4+ and CD8+
populations in all individuals, whereas other
gene segment families showed an apparent skew-
ing to one subpopulation in some but not all indi-
viduals. For instance, V]/1 showed a skewing to
the CD4-CD8+ population in KBI, FBI, and MBI,
whereas Vf114 was preferentially used in the
CD4--CD8+ population in KBI, FBI, and ZBI but
not MBI. Likewise, Vf118 was skewed to the
CD4+CD8- population in FBI, MBI, and ZBI (Fig.
2).
TcR Vcz-gene family usage.
To study the TcR Vcz-gene segment use, 22 differ-
ent Vcz-gene segment families were analyzed.
The results of these studies’are depicted in Fig. 3.
Differences in the frequency of use of the various
TcR V cz families are more pronounced in the
CD4+CD8- and CD4-CD8+ populations within
one individual, compared to the TcR V-gene
segment use (Fig. 3). For instance, in the sibling
FBI, Vo15 and Vcz16 seem to be more frequently
used in the CD4-CD8+ subset, whereas in the
father ZBI, amplification of Vcz15 and 16 was
comparable in both subsets (Fig. 3). In the
CD4+CD8- subculture of the type-III BLS
patient, a clear diminished use of the Vzl, 2, 3, 7
families could be observed, which was not seen
in the healthy family controls in addition to
biased expression in the CD4-CD8+ subset of
various other TcR Vcz-gene segments not seen in
healthy controls. The most striking difference,
however, was the apparent low frequency of use
of the TcR Vcz12-gene segment in the patient both
in the CD4+CD8- and CD4-CD8+ subsets.
To confirm the random TcR Vcz and V]/use in
the CD4+CD8- T-cell subset in the type-III BLS
patient, the V-gene segment use in TcR expressed
on several CD4+CD8- T-cell clones was ana-
lyzed. The clonality of these clones was tested by
gene rearrangement analysis of the TcRfl chain
using the restriction enzymes Eco RI and Hind III
and a C]/probe (data not shown). As in the bulk
culture, no preferential or restricted use of a
given TcR Vcz- and Vl/-gene family could be
detected in these clones (Table 3). Of note is that
in three clones, the Vf119-gene segment could be
amplified specifically, which might account for
the preferential use observed in the analysis of
the bulk culture. As in the CD4+CD8- and
CD4-CD8+ bulk cultures, none of the clones ana-
lyzed used the TcR Vcd2-gene segment.234 M. LAMBERT et al.
DISCUSSION
The type-III Bare Lymphocyte Syndrome pro-
vides a human model to study the influence of
the lack of MHC class-II antigen expression on
the composition of the peripheral T-cell compart-
ment. In this study, we have analyzed the impact
of the MHC class-II deficient environment on the
TcR V-gene segment usage in the CD4+CD8- and
CD4-CD8+ T-cell subsets. Our analysis showed
that for most of the V regions tested, no restricted
or u.nusual skewing in the frequency of employ-
ment of the various TcR Vet- and Vfl-gene seg-
ments could be detected. Both within the
CD4+CD8- as well as in the CD4-CD8+ T-cell
subset of the patient; the observed frequency of
TCR V-gene use for the majority of the TCR V-
gene segments tested was comparable to the
healthy family controls. However, in the patient,
most of the Vc-gene segments were used at
higher frequencies in the CD4-CD8+ T-cell sub-
set, in particular, the Vow1, 2, 3, and 7 genes. Of
note is that the Vct12-gene segment was used at
much lower frequencies both in the CD4+CD8-
and CD4-CD8+ subsets, in comparison to
healthy controls.
Our studies showed that in the frequency of
TcR Vo-gene segment use, more variation was
noticeable compared to V]/-gene segment use
between the CD4+CD8- T cells and CD4-CD8+ T
cells within one individual. This could be related
because most of the Vo-gene segment families
contain only one member, whereas the majority
of the VJ-gene segment families have more mem-
bers. As a result, differences in usage frequency
of the different Vfl subfamilies can be masked by
the amplification of other members of the same
family. The results from this study indicate that
in man, the impact of MHC class-II antigen
expression on T-cell development is more pro-
nounced on the TcR Vow- rather than on the V]/-
gene segment use. This in spite of the fact that
both the TcR Vet and V]/ chain seem to be
involved in binding of the peptide/MHC com-
plex (Chotia et al., 1988; Davis and Bjorkman,
1988).
Although our analyses show variety in TcR
Vow- and Vfl-gene segment use between the single
CD4+CD8- and CD4-CD8+ T-cell population,
the skewing of a particular V-gene segment to a
subset is less strong as observed in some mouse
strains. Several factors could contribute to this
difference between man and mouse. First, the
composition of the peripheral T-cell population is
not only influenced by the individual haplotype,
but also by the exposure to environmental
antigens and immunological activation at a given
moment. It should be noted that the analyzed
mice of various strains have been kept in a germ-
free state. Second, exposure to "self-super-
antigens" results in a skewing of certain TcR
gene segment positive T-cells to either the
CD4,CD8+ or CD4+CD8- subset (Benoist and
Mathis, 1989; Bill and Palmer, 1989; Blackman et
al., 1989; Liao et al., 1989) or to a complete
deletion of T cells bearing a TcR with certain
gene segments in both the CD4+CD8- and
CD4-CD8+ population (Kappler et al., 1988; Kisi-
elow et al., 1988; MacDonald et al., 1988a, 1988b;
Pircher et al., 1989). In mice several "self super-
antigens" are identified as endogenous retroviral
sequences (Dyson et al., 1991; Frankel et al., 1991;
Marrack et al., 1991; Woodland et al., 1991), but
no human analogue has been found so far. Third,
in mice, lack of use of a particular V-gene seg-
ment also resulted from deletion of part of the V-
gene segments on the genomic level as deter-
mined by Southern blot analysis of the TcR loci
both in inbred and in wild mice (Behlke et al.,
1986; Haqqi et al., 1989a, 1989b; Pullen et al.,
1990). In man, no major deletion of V-gene seg-
ments could be detected in most individuals
(Concannon et al., 1987; Baccala et al., 1991).
Fourth, most of the analyzed mice are homo-
zygous, whereas our analyzed individuals are
heterozygous. This heterozygocity could mask
the influence of the haplotype on the peripheral
T-cell compartment.
The presence of single CD4+CD8- T cells in the
periphery of this MHC class-II deficient patient is
in seemingly contradiction with studies in the
mouse in which interference in the TcR/MHC
class-II interaction leads to an almost complete
lack of CD4+CD8- T cells in the periphery
(Kruisbeek et al., 1983, 1985). Recently, MHC
class-II deficient mice have been generated by
homologous recombination. Here, the lack of
MHC class-II antigen expression in these mice
resulted in a strong reduction in the number of
single CD4+CD8- T cells in the periphery
(Cosgrove et al., 1991; Grusby et al., 1991). Of
note is the observation that despite the lack of
expression of the to-date known mouse MHC
class-II structures that are responsible for theT-CELL SUBCULTURES DERIVED FROM A TYPE-III 235
generation of the CD4+CD8- T-cell subset, the
periphery of these mice is not devoid of
CD4+CD8- T cells. In these mice, small numbers
of CD4+CD8- T cells can be found that exhibit
random use of the TCR V-gene segments tested
for (Cosgrove et al., 1991; Grusby et al., 1991).
These observations are reminiscent of the results
from this study in which we have demonstrated
that in a human model with no detectable periph-
eral MHC class-II expression, CD4+CD8- T cells
can be found in the periphery, albeit their num-
bers are greatly reduced. Furthermore, these
CD4+CD8- T cells are.not restricted in their TcR
V-gene segment use, indicating that these cells
are not derived from an oligoclonal outgrowth of
a few CD4+CD8- T cells that have escaped from
the thymic selection process. It is at present not
clear whether the observed skewing in the use
frequency of some of the TcR V-gene segments in
the T-cell subsets is a direct consequence of
aberrant thymic selection processes or that it is
resulting from a lack of MHC class-II mediated
postthymic modification of the peripheral T-cell
compartment.
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